Review Article Sri Lanka Dental Journal 2016; 46(01) 05-13
|
|
- Amanda Griffith
- 5 years ago
- Views:
Transcription
1 Review Article Sri Lanka Dental Journal 2016; 46(01) The Importance of Knowing the Patient s Clotting Profile before Dental Treatment N.A. Alles, N.S. Soysa Introduction Patients having bleeding disorders have an increased risk of significant bleeding from invasive dental and oral surgery procedures. Excessive bleeding poses a heavy burden especially on general dental practitioners as many private dental clinics are not equipped to deal with profuse bleeding encountered in patients with bleeding disorders. In addition to the promotion of prevention of dental diseases, the emergence of newer materials, local haemostatic agents and minimally invasive procedures have disencumbered the difficulties encountered in managing patients having bleeding disorders like hemophilia during invasive dental treatment procedures. Not only congenital disorders congenital disorders, liver diseases such as cirrhosis, platelet deficiency, scurvy, but also chronic anticoagulant therapy cause prolonged bleeding in patients following invasive dental treatment. Therefore, understanding the bleeding and coagulation profiles of a patient is important for the safe and successful management of dental patients in both private and government hospitals. Hemostasis requires intact endothelium, an adequate number of platelets, clotting factors and the von Willibrand Factor (vwf) which facilitates platelet adherence to the damaged endothelial wall. The process of hemostasis can be described under primary hemostasis, secondary hemostasis, formation and stabilization of fibrin clot and fibrinolysis. In the event of an injury, primary hemostasis takes place which results in the contraction of the smooth muscles of the blood vessels to minimize the opening of the injury or the penetration of vessel followed by the adherence of platelets to the injured site forming a platelet plug with the aid of the vwf (Figure 1). Once adhered to the injured site, platelets change their morphology and degranulate attracting more and more platelets to the site to close the opening. The inactive soluble clotting factors in the circulation become activated as a result of the activation of the coagulation/ clotting cascade in the secondary hemostasis, and then form the fibrin which entraps platelets and red blood cells (RBCs) resulting in the organized clot 1. Hence, a better understating of the role of the platelets and coagulation cascade which is measured by coagulation tests such as the thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (aptt) are important 2 when handling dental patients who require invasive dental treatments such as extractions, periodontal surgery and other minor surgeries etc. Platelets Platelets are derived from megakaryocytes and have a life span of 7-12 days. Platelets are usually stored and recycled in the spleen. Activation of platelets result in degranulation of certain Dr. N.A. Alles Dr. N.S. Soysa (Correspondence) (BVSc, PhD), Department of Biochemistry, Faculty of Medicine, University of Peradeniya. (BDS, PhD) Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya. niroshanis@pdn.ac.lk 5
2 N.A. Alles, N.S. Soysa Figure 1. molecules including adenosine diphosphate (ADP), serotonin, calcium, fibrinogen, the platelet factor 4, clotting factor V, platelet-derived growth factor (PDGF), thrombospondin, and the vwf (Figure 2). With the aid of vwf, platelets adhere to the injured site of the endothelium and release the aforementioned chemical mediators attracting more and more platelets in addition to activating clotting cascade and vasoconstriction (Figure 1). Attachment of platelet-to-platelet occurs through fibrinogen which is bound to the glycoprotein IIb-IIIa receptors on the platelet surface 3 (Figure 2). Once activated, platelets synthesize the vasoconstrictor thromboxane A2 (TXA 2 ) from arachidonic acid via the cyclooxygenase (COX) pathway. The appearance of negatively charged phospholipids on the surface of platelets activates the intrinsic pathway of coagulation cascade. The clotting factor V (labile factor) is released by the platelets, further facilitating the clotting cascade. Finally, platelet actinomycin contracts, pulling the clot into a tight plug 4. The normal platelet count is usually lies within the range of x 10 9 /L (150, 000 to 450, 000 cells/mm 3 ). The acceptable lower value for dental surgery is 50 x 10 9 /L 5. Though patients having counts of less than 100 x 10 9 /L might bleed, the local measures such as suturing and the placing of a haemostatic is adequate to control the bleeding successfully. Lower platelet counts less than 50 x 10 9 /L (50,000 cells/mm 3 ) require replacement therapy 5. Usually it is recommended to administer platelet (transfusion) 30 minutes prior to surgery. In the event of immune-mediated idiopathic thrombocytopenia, pre-operative oral systemic steroids are given for 7 to 10 days to increase the platelet counts to a more acceptable level 6. A novel method of analyzing platelet function using PFA-100, a platelet function analyzer (PFA) has been developed to screen the function of platelets. In the event of unavailability of this PFA-100, measuring bleeding time is also effective in delineating the platelet function. Bleeding time of 3 to 8 minutes gives an idea about intact platelet function, vwf, and an intact coagulation cascade. Bleeding Time Bleeding time measures the time taken to form the hemostatic plug after a standard skin incision (a superficial incision which is less than 1 mm deep and 1 cm long) of the forearm (or earlobe) using a special instrument. The Duke 6
3 The Importance of Knowing the Patient s Clotting Profile before Dental Treatment Figure 2. method and Ivy method are some of the methods available to perform bleeding time. The normal range of the Ivy Bleeding Time Test is usually between 2 and 10 minutes. In addition, there are several commercially available bleeding time devices such as the Simplate and Surgicutt. Von Willibrand Factor (vwf) The von Willebrand factor (vwf) is synthesized by endothelial cells as well as platelets. The vwf facilitates the adherence of platelets to the damaged vessel walls. Lack of vwf results in bleeding due to the inability of platelets to adhere to the vessel wall and their subsequent activation and degranulation. Moreover, vwf acts as a carrier for clotting factor VIII thereby, preventing its degradation and prolonging the half-life of factor VIII. In fine, deficiency of vwf reduces platelet adherence, activation as well as the levels of factor VIII. Clotting Factors Secondary hemostasis occurs as a result of intricate and interrelated systems of coagulation cascade. The inactive clotting factors (Table 1) get activated via two pathways; namely intrinsic and extrinsic pathways (Figure 3). The activation of intrinsic pathway involves initial activation of inactive factor XII by the negatively charged collagen found in the damaged endothelium. This initiates a cascade of events leading to the common pathway, where intrinsic and extrinsic pathways converge to form insoluble fibrin from fibrinogen (Figure 3). In the laboratory, the intactness of intrinsic pathway is performed by measuring the activated partial thromboplastin time (aptt). The activation of extrinsic pathway occurs subsequent to the release of tissue factor following endothelial damage. This activates the factor VII (proconvertin or stable factor) and ultimately the common pathway. The activation of common pathway involves the activation of factor X (Stuart factor) which in turn converts prothrombin (factor II) to thrombin, and finally fibrinogen (factor I) to fibrin. In addition, thrombin enhances the conversion of Factor V to Va, Factor VIII to VIIIa and thus amplifying the coagulation cascade. Prothrombin time (PT) is used to assess the integrity of extrinsic and common pathways (Figure 3). Except for factor VII, almost all the clotting factors are synthesized in the liver and in addition, vitamin K is required for the synthesis of factor II (prothrombin), factor VII, factor IX (Christmas factor), and factor X. The anticoagulant warfarin interferes with the synthesis of vitamin K dependent factors by preventing the reduction of vitamin K. 7
4 N.A. Alles, N.S. Soysa Table 1. Factor Name Comments I Fibrinogen II Prothrombin Vitamin K dependent factor III Thromboplastin IV Calcium V Labile factor VII Proconvertin or stable factor Vitamin K dependent factor VIII Antihemophilic factor IX Christmas factor Vitamin K dependent factor X Stuart factor Vitamin K dependent factor XI Plasma thromboplastin antecedent XII Hageman factor XIII Fibrin-stabilizing factor Figure 3. Prothrombin time (PT) Prothrombin time (PT) measures the function of the extrinsic pathway (Figure 4). Factor III or tissue factor (also known as thromboplastin or CD142), which is a transmembrane protein that activates factor VII and initiates the extrinsic coagulation pathway. The tissue factor is expressed by cells of non-vascular origin as well as by subendothelial tissues and leukocytes (monocytes). Since three of the clotting factors 8 involved (II, VII, X) are vitamin K dependent, PT is also used to measure liver function. In the laboratory, PT is measured by mixing calcium and thromboplastin with citrated plasma (blood is collected into a tube with sodium citrate which chelates calcium thus preventing blood clotting during transport) and then allowing it to coagulate. The time taken to form the clot is considered as PT (Figure 4). Though the normal value of PT varies from lab to lab, usually
5 The Importance of Knowing the Patient s Clotting Profile before Dental Treatment the normal PT ranges from 9 to 15 seconds. However, the PT should be always compared to the reference range given by the particular laboratory. Thromboplastin is usually derived from animal tissues that provide the tissue factor as well as phospholipids (PL) necessary for the activation of factor VII and then factor X. Due to the differences in commerciallyproduced thromboplastins throughout the world, the World Health Organization (WHO) introduced the International Normalized Ratio (INR) which is devised to normalize the clotting time by correcting the differences in reagent responsiveness, and to facilitate the standardization of laboratory testing of PT 7. Thromboplastin used by each laboratory is tested against an international standard and then the relationship is given as international sensitivity index (ISI). The INR uses the ISI to equate all thromboplastins to the reference thromboplastin and commercial suppliers of thromboplastin usually gives the ISI with each reagent lot. If the ISI is known, the INR is easily calculated through the following equation: INR = (patient PT/mean normal PT) ISI Normally, thromboplastins with lower ISI values (close to 1) are more accurate and show the effects of anticoagulants such as warfarin well and also have a longer PT. For example, when a blood sample is analyzed using two thromboplastin reagents with two different ISIs, the PT will be higher with the more sensitive (lower ISI) thromboplastin than with less sensitive (higher ISI) thromboplastin; however, the INR values will be equivalent in both situations. The normal value of the INR for a healthy person ranges between Depending on the type of medical condition, the desirable INR given for patients on anticoagulant therapy varies and needs to be within the theraputic range; however, usually it is less than 4.0. It is advisable to measure the INR of patients on warfarin therapy before invasive dental treatments 8. Figure 4. 9
6 N.A. Alles, N.S. Soysa Activated Partial Thromboplastin Time (aptt) This test evaluates the intrinsic and common pathways of blood coagulation. Activated partial thromboplastin time (aptt) gives an idea about the deficiencies of the clotting factors in the intrinsic pathway such as XII, XI, IX, VIII, and the common pathway factors X and V and prothrombin and fibrinogen (Figure 4). A normal aptt is about 25 to 40 seconds. The various aptt reagents contain phospholipids and a specific contact activator. The aptt is commonly employed in monitoring heparin therapy and to diagnose hemophilias (Table 2). Thrombin Time (TT) Thrombin Time (TT) denotes the formation of an insoluble clot by conversion of fibrinogen to insoluble fibrin. TT evaluates lack of fibrinogen or the presence of an inhibitor of thrombin (Factor IIa). Anticoagulant drug therapy (e.g. heparin or direct thrombin inhibitor) causes prolongation of TT. This laboratory test is performed by adding thrombin to the patient s blood sample which circumvents the intrinsic, extrinsic and common pathways to determine the stability of the clot. Thrombin Time (TT) ranges between 9 to 13 seconds. Table 2. Test Normal range Conditions with normal vales Conditions with elevated vales Conditions with reduced vales Bleeding time aptt 3-8 min s Hemophilia A and B Von Willebrand disease Hemophilia A and B, disseminated intravascular coagulation (DIC), liver disease, vitamin K deficiency, warfarin therapy PT INR TT Factor V Factor VII 9-15 s s % Hemophilia A and B Vitamin K deficiency DIC, liver disease, vitamin K deficiency,warfarin therapy Liver disease, DIC Liver disease, vitamin K deficiency, DIC Factor VIII % Liver disease, vitamin K deficiency Liver disease Hemophilia A, von Willebrand disease, DIC 10
7 The Importance of Knowing the Patient s Clotting Profile before Dental Treatment Management of Bleeding During Dental Procedures Systemic Therapies Unlike patients having severe and moderate haemophilia which give rise to spontaneous bleeding, mild haemophilia may not be diagnosed until a procedure such as a dental extraction causes prolonged bleeding. If it is known that the patient is having haemophilia, it is imperative that dental treatments are scheduled to be performed \at times of factor administration and thereby reduce the risks of therapies subsequent to heavy bleeding. Clinical manifestations of von Willebrand disease might include signs and symptoms such as mucocutaneous haemorrhage and gingival bleeding which are characteristic features of platelet dysfunction. However, if not diagnosed previously, bleeding after dental extractions may be a presenting feature of the von Willebrand disease. Factor XI deficiency might manifest by mild unpredictable bleeding which may aggravate following surgery such as tonsillectomy and dental procedures in areas with high fibrinolytic activity. Since the current practice is to use factor concentrates for all known factor deficiencies, if available, management of the condition requires administration of fresh frozen plasma or the administration of factor XI concentrates in addition to antifibrinolytics. In fine, the aforementioned bleeding disorders require coagulation factor replacement, desmopressin (DDAVP) to release endogenous factor stores, antifibrinolytics and local measures to achieve hemostasis following invasive dental procedures. However, oral examinations, application of fissure sealants, small occlusal restorations without local anesthesia and supragingival scaling do not require such therapy 9. Though local anesthetic infiltration can be achieved by slow injection technique with a fine gauge single-use needle without factor replacement therapy, augmentation of factor levels with or without tranexamic acid is required when inferior alveolar and posterior superior alveolar dental nerve blocks are given in patients having hemophilia Therefore it is obvious that depending on the bleeding disorder and the type of dental procedure, the type of systemic therapies varies and the decision for coagulation factor replacement should be made with the consultation of a hematologist. It is advisable to perform invasive dental procedures which require factor replacement in a hospital setup which is more equipped with emergency management than a general practice. Use of Antifibrinolytic Agents Aminocaproic acid and tranexamic acid are synthetic products that prevent fibrinolysis by blocking the binding of plasminogen to fibrin and its subsequent activation to plasmin. Normally, plasminogen activators are abundant in oral mucosa. In addition, saliva shows ample fibrinolytic activity. Therefore, aminocaproic acid and tranexamic acid can be administered to prevent clot lysis after oral surgery or dental extractions. For example, it has been shown that tranexamic acid significantly reduces the risk of delayed bleeding and the amount of clotting factor replacement therapy required after dental surgery in haemophiliacs 10. In those instances, administration of tranexamic acid commences before surgery at a dose of 25 mg/kg t.i.d and continues for 3-5 days as post extraction therapy. These agents are also available as mouthwashes; therefore, can be used as a local therapy in patients on oral anticoagulants, without reducing or withholding the anticoagulant therapy 11. Patients on Antithrombotic/Anticoagulant Therapy Earlier, the common practice was to discontinue medication such as warfarin for at least 2 days before dental procedures in patients on longterm anticoagulation or antiplatelet therapy. However, due to the fact that the risk of thromboembolism outweighs the beneficial effects of temporary cessation of therapy, it is not advisable to stop taking warfarin during dental treatments, provided that the INR is within the acceptable range. Moreover, it has
8 N.A. Alles, N.S. Soysa been shown that local measures are adequate to prevent or reduce the bleeding 8. A systematic review and a meta analysis revealed that continuing the regular warfarin therapy does not cause excessive bleeding compared to that of discontinuing or modifying the dose for patients who undergo minor dental procedures such as dental extractions Managing Postoperative Bleeding of Patients on warfarin after Extraction: 1. packing the sockets with oxidized cellulose, reabsorbable collagen sponges, fibrin adhesives, tissue adhesives and suturing 2. application of pressure packs - it is important to keep the pressure pack at the extraction socket at least ½ hr without checking it for bleeding at the extraction socket 3. additional injection of a local anesthetic with epinephrine to retard the bleeding and enhances the vessel constriction, platelet plug formation and stable clot formation 4. advice the patients to limit physical exertion, rinsing the mouth, sucking or chewing food on the affected side until the clot is formed 5. advice patients to refrain from taking NSAIDS as pain killers following dental treatment since, patients may experience pain or discomfort once the local anesthesia wanes off. Paracetamol is the safest analgesic for patients at risk of bleeding (e.g. patientss on warfarin) after invasive dental treatments. There are several lines of evidence to show that when combined with local hemostatic measures and suturing, tranexamic acid mouthwashes do not provide additional effects in reducing postoperative bleeding 14. Summary Excessive bleeding following minor dental procedures such as extractions preclude the dentists to handle patients having bleeding disorders and antithrombotic therapies including warfarin therapy. However, evidence indicates that the cessation of anticoagulant therapies is not indicated given the fact that the patient s INR is obtained prior to the invasive procedure and the local hemostatic measures are available at hand. This signifies the importance of understanding hemostasis and the various laboratory tests used to evaluate bleeding in dental patients. References 1. Platt, A. Understanding and treating disorders of the clotting system. JAAPA Off. J. Am. Acad. Physician Assist. 20, (2007). 2. Mani, H. Interpretation of coagulation test results under direct oral anticoagulants. Int. J. Lab. Hematol. 36, (2014). 3. Vorchheimer, D. A. & Becker, R. Platelets in atherothrombosis. Mayo Clin. Proc. 81, (2006). 4. Kickler., T. Platelet biology - an overview. Transfus. Altern. Transfus. Med. 2, (2006). 5. Gupta A1, Epstein JB, Cabay RJ. Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc, 73(1):77-83( 2007). 6. Meechan, J. G. & Greenwood, M. General medicine and surgery for dental practitioners Part 9: haematology and patients with bleeding problems. Br. Dent. J. 195, (2003). 7. Stern, R., Karlis, V., Kinney, L. & Glickman, R. Using the international normalized ratio to standardize prothrombin time. J. Am. Dent. Assoc , (1997). 8. Soysa, N. Managing patients receiving warfarin therapy in general dental practice. Gen. Dent. Pract. 30, (2013). 12
9 The Importance of Knowing the Patient s Clotting Profile before Dental Treatment 9. Anderson, J. a. M. et al. Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br. Dent. J. 215, (2013). 10. Sindet-Pedersen, S. & Stenbjerg, S. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg. 44, (1986). 11. Israels, S., Schwetz, N., Boyar, R. & McNicol, A. Bleeding disorders: characterization, dental considerations and management. J. Can. Dent. Assoc. 72, 827 (2006). 12. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review andmeta-analysis.tex Dent J Dec;126(12): Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review andmeta-analysis.j Can Dent Assoc Feb;75(1): van Galen KP, Engelen ET, Mauser- Bunschoten EP, van Es RJ, Schutgens RE. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev Dec 24;12:CD
Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
More informationThis slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion
This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationAnatomy and Physiology
Anatomy and Physiology For The First Class 2 nd Semester Thrombocytes = Platelets Thrombocytes = Platelets Blood platelets are non-nucleated disc like cell fragments 2-4 µm in diameter. Platelets are not
More informationHemostasis and. Blood Coagulation
Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis is achieved by several mechanisms: (1) vascular
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationTopics of today lectures: Hemostasis
Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood
More informationBleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph
Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)
More informationUNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood
More informationPhysiology of. The Blood hemostasis. By prof. Israa f. jaafar
Physiology of The Blood hemostasis By prof. Israa f. jaafar Learning objectives Understand the Platelet structure and function Explane the Platelet production Understand the phases of hemostasis: vascular
More informationCh. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma
Chapt. 45 Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma Inheritance of X-linked gene for Factor VIII hemophilia A Explain the
More informationPart IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
More informationPHM142 Lecture 4: Platelets + Endothelial Cells
PHM142 Lecture 4: Platelets + Endothelial Cells 1 Hematopoiesis 2 Platelets Critical in clotting - activated by subendothelial matrix proteins (e.g. collagen, fibronectin, von Willebrand factor) and thrombin
More information"DENTAL MANAGEMENT OF A PATIENT TAKING ANTICOAGULANTS"
"DENTAL MANAGEMENT OF A PATIENT TAKING ANTICOAGULANTS" ------------------------------------------------------------------------ LT J.D. Molinaro, DC, USN 11 August 2000 Introduction Any patient receiving
More informationBleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon
Bleeding and Haemostasis Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon 1 Beeding Its escaping or extravasation of blood contents from blood vessels Types: - Arterial - Venous - Capillary Differences
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
١ Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationBlood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )
Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM
More informationHemostasis and Thrombosis
Hemostasis Hemostasis and Thrombosis Normal hemostasis is a consequence of tightly regulated processes that maintain blood in a fluid state in normal vessels, yet also permit the rapid formation of a hemostatic
More informationHemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot
Hemostasis Clo)ng factors and Coagula4on Dr Badri Paudel www.badripaudel.com Hemostasis is defined as a property of circula4on whereby blood is maintained within a vessel and the ability of the system
More information-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record.
* Subjects of this lecture : - Hemostasis - Platelets, general information, their ultrastructure and role in hemostasis. - Definitions: Thrombus, Embolus, Arteriosclerosis and Atherosclerosis. *NOTE: Prof
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationDr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN
Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets
More informationOral Anticoagulant Drugs
Oral Anticoagulant Drugs Spoiled sweet clover caused hemorrhage in cattle(1930s). Substance identified as bishydroxycoumarin. Initially used as rodenticides, still very effective, more than strychnine.
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
1 Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationCoagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University
In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationMoath Darweesh. Omar Sami. Saleem Khreisha. 1 P a g e
7 Moath Darweesh Omar Sami Saleem Khreisha 1 P a g e -First of all, I want to give a quick revision to simplify the whole hemostasis mechanism, it will be much easier here with me. Enjoy (you can skip
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. HEMOSTASIS AND THE LABORATORY This issue highlights: Primary Hemostasis Screening Tests Case
More informationDental Management of Patients with Bleeding Disorders
Dental Management of Patients with Bleeding Disorders Sandra D Amato-Palumbo, RDH, MPS Continuing Education Units: 3 hours Online Course: www.dentalcare.com/en-us/dental-education/continuing-education/ce319/ce319.aspx
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationBlood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.
Blood clotting It is the conversion, catalyzed by thrombin, of the soluble plasma protein fibrinogen (factor I) into polymeric fibrin, which is deposited as a fibrous network in the primary thrombus. Thrombin
More informationRoutine preoperative coagulation tests: are they necessary?
Routine preoperative coagulation tests: are they necessary? Dr Azzah Alzahrani MD Pediatrics Hematology /Oncology PSMMS Outline Introduction. Brief review of hemostatic mechanisms. A clinical aspect of
More informationBleeding, Coagulopathy, and Thrombosis in the Injured Patient
Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial
More informationJohn Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne
John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation
More informationPHASES OF HAEMOSTASIS
HAEMOSTASIS Maintains the integrity of a closed, highpressure circulatory system after vascular damage Vessel Wall Injury events in the vessel wall and in the blood which seal breach Delicate balance exists
More informationM B Garvey. University of Toronto
Do I really need that test??? M B Garvey Professor Emeritus University of Toronto St Michael s Hospital No relevant conflicts of interest 1 HEMOSTASIS IS LIKE LOVE Everybody talks about it, nobody understands
More informationChapter 19 Blood Lecture Outline
Chapter 19 Blood Lecture Outline Cardiovascular system Circulatory system Blood 1. distribution 2. regulation 3. protection Characteristics: ph 7.4 38 C 4-6 L Composition: Plasma Formed elements Erythrocytes
More informationPage 1 of 6 THROMBOCYTES
Page 1 of 6 THROMBOCYTES Platelets are not cells in the strict sense. About one-fourth the diameter of a lymphocyte, they are cytoplasmic fragments of extraordinarily large cells (up to 60 µm in diameter)
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationApproach To A Bleeding Patient
ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationBlood platelets play important role in coagulation.
B.N. Bandodkar College of Science, Thane T.Y. B.Sc Paper II Haematology Blood Coagulation / Blood clotting By Dr N.N. Patil Introduction: When blood is shed, it looses its fluidity within few minutes and
More informationPathology note 8 BLEEDING DISORDER
Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more
More informationBlood Lecture Test Questions Set 2 Summer 2012
Blood Lecture Test Questions Set 2 Summer 2012 1. Leukocytes are attracted to a site of injury or disease by: a. diapedesis b. chemotaxis c. leukocytosis d. heparin e. leukomotosis 2. Leukocytes leave
More informationBleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury.
1 Bleeding disorders Objectives: 1. Discuss briefly the physiology of hemostasis. 2. Define the mechanisms of thrombocytopenia and the relative bleeding risk at any given platelet count. 3. Be able to
More informationAnticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT
Haemostasis Thrombosis Phases Endogenous anticoagulants Stopping blood loss Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT Vascular Platelet
More informationDiagnosis of hypercoagulability is by. Molecular markers
Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna
More informationProthrombin Complex Concentrate- Octaplex. Octaplex
Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation
More informationWHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION
WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT ARTICLES OUR STUDY BLEEDING CONTROL 5 POINT MODEL WO NDCLOT The WoundClot Principals for Effective Bleeding Control PRESENTATION Harnessing SCIENCE
More informationChapter 3. Haemostatic abnormalities in patients with liver disease
Chapter 3 Haemostatic abnormalities in patients with liver disease Ton Lisman, Frank W.G. Leebeek 1, and Philip G. de Groot Thrombosis and Haemostasis Laboratory, Department of Haematology, University
More informationHemodynamic Disorders, Thromboembolic Disease, and Shock
Hemodynamic Disorders, Thromboembolic Disease, and Shock Kumar et al: Robbins & Cotran Pathologic Basis of Disease 7E Figure 4-1 Factors affecting fluid balance across capillary walls. Capillary hydrostatic
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationGeneral approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013
General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding
More informationBIOH122 Human Biological Science 2
BIOH122 Human Biological Science 2 Session 2 Haematological System Haemostasis and Blood Groups Bioscience Department Endeavour College of Natural Health endeavour.edu.au Session Plan o Platelets Properties
More informationANTICOAGULANTS & FIBRINOLYTIC AGENTS Chapter 34
ANTICOAGULANTS & FIBRINOLYTIC AGENTS Chapter 34 Dr. Azadeh Mesripour (Ph.D) Pharm.MUI 2015 Dr. Mesripour 1 Platelet membrane receptors include the glycoprotein (GP) Ia receptor, binding to collagen (C);
More informationPlatelet-fibrin clot. 50Kd STEMI. Abciximab. Video of a IIb/IIIa inhibitor in action. Unstable Angina and non-stsegment
Objectives IIb/IIIa, Vitamin K, and Direct Thrombin Inhibition in Cardiology Michael Gulseth, Pharm. D., BCPS Assistant Professor, Duluth Pharmacy 6122 February 14, 2005 Describe the pharmacology, kinetics,
More informationThrombosis. Jeffrey Jhang, M.D.
Thrombosis Jeffrey Jhang, M.D. Introduction The human hemostatic system has evolved to maintain blood flow under normal physiologic conditions while remaining primed to rapidly respond to vascular injury
More information>>FAST TRACK<< Hemostasis has three key components: platelets, the plasma coagulation. cascade, and the blood vessel wall (endothelium).
How to Reverse an Antithrombotic Agent The authors review options and precautions to consider when you need to restore hemostasis in a patient receiving an anticoagulant, antiplatelet, or fibrinolytic
More informationTREATMENT & MANAGEMENT OF VON WILLEBRAND DISEASE
TREATMENT & MANAGEMENT OF VON WILLEBRAND DISEASE Dr Susan Russell Director HTC Sydney Children s Hospital, Randwick HFA Meeting 2015 What is von Willebrand Factor? VWF is a large multimeric protein Two
More informationWhat are blood clots?
What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew
More informationInstruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich
ADP (Adenosine-5 -Diphosphate) 101312 3 x 0.5mL ADP is a lyophilized preparation of adenosine-5 -diphosphate. The working concentration of the reconstituted reagent is 2 x 10-4 M. ADP is for use in routine
More informationCOAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
COAGULATIONS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin) Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following
More informationLocal vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors
Hemostasis Hemostasis ( hemo =blood; sta= remain ) is the stoppage of bleeding, which is vitally important when blood vessels are damaged. Following an injury to blood vessels several actions may help
More informationDisseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS
به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation
More informationEasy bruising vs Coagulopathy
Easy bruising vs Coagulopathy Sept. 19, 2015 Lakehead Summer School Chris Hillis, MD MSc FRCPC hillis@hhsc.ca @HemeHillis Aim & Objectives Aim: To increase comfort in detecting non-pathologic bleeding
More informationHemostasis. Coagulation vs anticoagulation
Hemostasis is a process of forming clots in the wall of damaged blood vessels and preventing blood loss while maintaining blood in fluid state within the vascular system. Coagulation vs anticoagulation
More informationBleeding and Thrombotic Disorders. Kristine Krafts, M.D.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden
More informationBranch of medicine that deals with blood, its formation and disorders is called. Three main functions of cardiovascular system are,, and.
Chapter 19 The Blood Human body must maintain a balance called. Body fluid inside the cells is called fluid; that outside is called or fluid. Two major fluid networks that help in connecting cells are
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationHaemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College
Haemorrhagic Disorders Dr. Bashar Department of Pathology Mosul Medical College Hemorrhagic Disorders These include Disorders of platelets. Disorders of blood vessels. Disorders of coagulation & fibrinolysis.
More informationvan Galen KPM, Engelen ET, Mauser-Bunschoten EP, van Es RJJ, Schutgens REG
Cochrane Database of Systematic Reviews Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions(review)
More informationCoagulation, Haemostasis and interpretation of Coagulation tests
Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect
More informationChapter 19 Cardiovascular System Blood: Functions. Plasma
Chapter 19 Cardiovascular System Blood: Functions 19-1 Plasma Liquid part of blood. Colloid: liquid containing suspended substances that don t settle out of solution 91% water. Remainder proteins, ions,
More informationAgent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min
Nanik (Nayri) Hatsakorzian Pharm.D/MPH candidate 2014 Touro University College of Pharmacy CA Bleeding Reversal Agents Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes
More informationBLEEDING AFTER EXTRACTION
Course: DENTOALVEOLAR SURGERY 1 BLEEDING AFTER EXTRACTION Assoc. Prof. Peter STANKO, MD, PhD oral and maxillofacial surgeon Comenius University in Bratislava, Faculty of Medicine Dpt. Stomatology & Maxillofacial
More informationSysmex Educational Enhancement and Development No
SEED Coagulation Sysmex Educational Enhancement and Development No 2 2016 An approach to the bleeding patient The purpose of this newsletter is to provide an overview of the approach to the bleeding patient
More informationMANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore
MANAGEMENT OF COMMON BLEEDING DISORDERS Auro Viswabandya Department of Haematology, CMC, Vellore BLOOD CLOT : PRIMARY HAEMOSTASIS (Platelets) + SECONDARY HAEMOSTASIS (Coagulation Factors) HAEMOSTATIC DISORDERS
More informationFIGURE 1. Coagulation cascade. a = activated factor; Ca = calcium; PL = phospholipid. Adapted from Biochemistry, 2 with permission from American Chemi
CONCISE REVIEW FOR CLINICIANS PROLONGED PT AND APTT How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults ARIF H. KAMAL, MD; AYALEW
More informationDr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College
Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction
More informationTHROMBOTIC DISORDERS: The Final Frontier
THROMBOTIC DISORDERS: The Final Frontier Jeffrey I. Weitz, MD, FRCP(C), FACP Professor of Medicine and Biochemistry McMaster University Canada Research Chair in Thrombosis Heart & Stroke Foundation/ J.F.
More informationCLINICAL FELLOWSHIP PROGRAM IN COAGULATION
CLINICAL FELLOWSHIP PROGRAM IN COAGULATION The Department of Pathology and Laboratory Medicine University of Alberta, Faculty of Medicine and Dentistry and Alberta Health Services CLINICAL FELLOWSHIP IN
More informationHemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands
Hemostasis and thrombosis in patients with liver disease Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Importance of the liver in hemostasis Synthesis of Coagulation factors Fibrinolytic proteins
More informationEasy Bleeding General Presentation
Easy Bleeding General Presentation It is not uncommon for children to bleed and bruise after experiencing trauma. However, a child may also have an underlying coagulopathy, which results in easy and possibly
More informationMANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY
MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):
More informationChapter 1 Introduction
Chapter 1 Introduction There are several disorders which carry an increased risk of thrombosis, clots that interfere with normal circulation, including: venous thromboembolism (VTE), comprising both deep
More informationChapter 11. Lecture and Animation Outline
Chapter 11 Lecture and Animation Outline To run the animations you must be in Slideshow View. Use the buttons on the animation to play, pause, and turn audio/text on or off. Please Note: Once you have
More informationAppendix 3 PCC Warfarin Reversal
Appendix 3 PCC Warfarin Reversal Reversal of Warfarin and Analogues 1. Principle of Procedure Guidelines for the Reversal of Oral-anticoagulation in the Event of Life Threatening Haemorrhage Prothrombin
More informationBleeding Disorders HOPE Maram Al-anbar
Bleeding Disorders HOPE Maram Al-anbar 9-9 - 2014 ^^ Attention Please ^^ We ( correction team of pediatric package^hope/2010^ ) had decided to make one lecture of bleeding disorders in place of the two
More informationStep 2. Common Blood Tests, and the Coulter Counter Readout
Step 2. Common Blood Tests, and the Coulter Counter Readout We will be learning about some common blood tests. We will not be preforming most of them in lab. The student should know their names, their
More informationGuidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting
More informationY. Helen Zhang, MD Andy Nguyen, MD 10/28/2012
Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012 Clinical History Patient: 23-year-old female Clinical course: status-post cholecystectomy, complicated by retained common bile duct stones. Following three
More information4/23/2009. September 15, 2008
The Current Treatment of Deep Venous Thrombosis: Are We Doing Enough? George H. Meier, MD Professor and Chief Division of Vascular Surgery University of Cincinnati College of Medicine Cincinnati, Ohio
More informationLiver transplantation has become a standard treatment for end-stage liver disease and
www.scielo.br/jaos Assessment and management of oral health in liver transplant candidates Paulo Sérgio da SILVA SANTOS 1, Karin Sá FERNANDES 2, Marina H. C. GALLOTTINI 3 1- PhD, Department of Stomatology,
More informationManaging Coagulopathy in Intensive Care Setting
Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More informationHEMOSTASIS AND LIVER DISEASE. P.M. Mannucci. Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy
HEMOSTASIS AND LIVER DISEASE P.M. Mannucci Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy 1964 ACQUIRED HEMOSTASIS DISORDERS: LIVER DISEASE Severe liver disease not uncommonly
More informationDocument Title: Hemostasis: Platelet and Coagulation Disorders. Author(s): Joseph H. Hartmann (University of Michigan), DO 2012
Project: Ghana Emergency Medicine Collaborative Document Title: Hemostasis: Platelet and Coagulation Disorders Author(s): Joseph H. Hartmann (University of Michigan), DO 2012 License: Unless otherwise
More informationChapter 14. Blood. Blood Volume. Blood Composition. Blood
Blood connective tissue transports vital substances maintains stability of interstitial fluid distributes heat Chapter 14 Blood Blood Cells form mostly in red bone marrow red blood cells white blood cells
More information